Journal article icon

Journal article

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

Abstract:

BACKGROUND:Plasmodium vivax malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for P. vivax, has been reported in the country and has potential to undermine local control efforts.

METHODS: Patients over 6 years of age with uncomplicated P. vivax mono-infection were enrolled into clinical efficacy studies in Myawaddy in 2014 and Kawthoung in 2012. Study particip...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More from this funder
Name:
Wellcome Trust
Grant:
200909
More from this funder
Name:
Bill and Melinda Gates Foundation
Grant:
OPP1054404
More from this funder
Name:
Australian Department of Foreign Affairs and Trade
Grant:
R150380
More from this funder
Name:
US Agency for International Development-President's Malaria Initiative
Publisher:
BioMed Central
Journal:
Malar J More from this journal
Volume:
16
Issue:
1
Pages:
281
Publication date:
2017-07-10
Acceptance date:
2017-06-26
DOI:
EISSN:
1475-2875
Language:
English
Keywords:
Pubs id:
pubs:708114
UUID:
uuid:918a1fb5-d5b9-44ab-b62d-c6c65ad7db4d
Local pid:
pubs:708114
Deposit date:
2017-07-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP